Clinical Trials Browser

Phase 3 × UNKNOWN × Colorectal Neoplasms × Clear all

NCT01694966 2017-11-06

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

Phase 3 Completed

1,249 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms